Combined administration of measles, mumps, rubella, and trivalent oral poliovirus vaccines. 1977

R D Krugman, and J J Witte, and P D Parkman, and K L Herrmann, and H M Meyer, and R D Wende, and B C Meyer, and R Dungca

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008457 Measles A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM. Rubeola
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D009107 Mumps An acute infectious disease caused by RUBULAVIRUS, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected. (From Dorland, 28th ed) Parotitis, Epidemic,Epidemic Parotitides,Epidemic Parotitis,Parotitides, Epidemic
D009108 Mumps Vaccine Vaccines used to prevent infection by MUMPS VIRUS. Best known is the live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine. Inactivated Mumps Vaccine,Inactivated Mumps Virus Vaccine,Live Attenuated Mumps Vaccine,Live Attenuated Mumps Virus Vaccine,Mumps Vaccine, Inactivated,Mumps Vaccine, Live Attenuated,Mumps Virus Vaccine, Inactivated,Mumps Virus Vaccine, Live Attenuated,Vaccine, Inactivated Mumps,Vaccine, Mumps
D011051 Poliomyelitis An acute infectious disease of humans, particularly children, caused by any of three serotypes of human poliovirus (POLIOVIRUS). Usually the infection is limited to the gastrointestinal tract and nasopharynx, and is often asymptomatic. The central nervous system, primarily the spinal cord, may be affected, leading to rapidly progressive paralysis, coarse FASCICULATION and hyporeflexia. Motor neurons are primarily affected. Encephalitis may also occur. The virus replicates in the nervous system, and may cause significant neuronal loss, most notably in the spinal cord. A rare related condition, nonpoliovirus poliomyelitis, may result from infections with nonpoliovirus enteroviruses. (From Adams et al., Principles of Neurology, 6th ed, pp764-5) Infantile Paralysis,Polio,Poliomyelitis, Nonpoliovirus,Poliomyelitis, Preparalytic,Encephalitis, Polio,Epidemic Acute Poliomyelitis,Polio Encephalitis,Poliomyelitis Infection,Poliomyelitis, Acute,Acute Poliomyelitis,Acute Poliomyelitis, Epidemic,Infection, Poliomyelitis,Infections, Poliomyelitis,Nonpoliovirus Poliomyelitis,Paralysis, Infantile,Poliomyelitides, Preparalytic,Poliomyelitis Infections,Poliomyelitis, Epidemic Acute,Polios,Preparalytic Poliomyelitis
D011055 Poliovirus Vaccine, Oral A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed) Sabin Vaccine,Oral Poliovirus Vaccine,Vaccine, Oral Poliovirus,Vaccine, Sabin
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

R D Krugman, and J J Witte, and P D Parkman, and K L Herrmann, and H M Meyer, and R D Wende, and B C Meyer, and R Dungca
February 1999, Vaccine,
R D Krugman, and J J Witte, and P D Parkman, and K L Herrmann, and H M Meyer, and R D Wende, and B C Meyer, and R Dungca
September 1978, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
R D Krugman, and J J Witte, and P D Parkman, and K L Herrmann, and H M Meyer, and R D Wende, and B C Meyer, and R Dungca
March 1969, JAMA,
R D Krugman, and J J Witte, and P D Parkman, and K L Herrmann, and H M Meyer, and R D Wende, and B C Meyer, and R Dungca
March 1990, Infectious disease clinics of North America,
R D Krugman, and J J Witte, and P D Parkman, and K L Herrmann, and H M Meyer, and R D Wende, and B C Meyer, and R Dungca
August 1993, American journal of diseases of children (1960),
R D Krugman, and J J Witte, and P D Parkman, and K L Herrmann, and H M Meyer, and R D Wende, and B C Meyer, and R Dungca
July 1990, The Pediatric infectious disease journal,
R D Krugman, and J J Witte, and P D Parkman, and K L Herrmann, and H M Meyer, and R D Wende, and B C Meyer, and R Dungca
October 1971, JAMA,
R D Krugman, and J J Witte, and P D Parkman, and K L Herrmann, and H M Meyer, and R D Wende, and B C Meyer, and R Dungca
February 1988, Pediatrics,
R D Krugman, and J J Witte, and P D Parkman, and K L Herrmann, and H M Meyer, and R D Wende, and B C Meyer, and R Dungca
June 2005, Biologicals : journal of the International Association of Biological Standardization,
R D Krugman, and J J Witte, and P D Parkman, and K L Herrmann, and H M Meyer, and R D Wende, and B C Meyer, and R Dungca
January 1974, Infection,
Copied contents to your clipboard!